Trial Profile
Efficacy and Safety of Bevacizumab + Hepatic Arterial Infusion Chemotherapy (FOLFIRI) in Patients with Unresectable Colorectal Liver Metastases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 23 Dec 2015 New trial record